Cornerstone Investment Partners’s Organogenesis Holdings ORGO Stock Holding History

Cornerstone Investment Partners’s Portfolio ORGO Stock Details ORGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-33,627	Closed	-$174K	–	321
2025 Q4	$174K	Buy	+33,627	New	+$163K	0.01%	194
2025 Q3	–	Sell	-45,977	Closed	-$168K	–	242
2025 Q2	$168K	Sell	45,977 -496	-1%	-$1.85K	0.01%	177
2025 Q1	$201K	Sell	46,473 -4,029	-8%	-$16.3K	0.01%	136
2024 Q4	$162K	Buy	+50,502	New	+$169K	0.01%	229
2024 Q1	–	Sell	-62,798	Closed	-$257K	–	261
2023 Q4	$257K	Buy	+62,798	New	+$176K	0.01%	135
2022 Q2	–	Sell	-12,970	Closed	-$99K	–	227
2022 Q1	$99K	Hold	12,970	–	–	0.01%	229
2021 Q4	$120K	Hold	12,970	–	–	0.01%	273
2021 Q3	$185K	Sell	12,970 -3,100	-19%	-$48.1K	0.01%	195
2021 Q2	$267K	Hold	16,070	–	–	0.01%	161
2021 Q1	$293K	Buy	+16,070	New	+$218K	0.02%	122

Other funds holding ORGO

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Cornerstone Investment Partners's ORGO Position: Q1 2026 in Review

Cornerstone Investment Partners sold out of Organogenesis Holdings (ORGO) in Q1 2026, closing a stake of 33,627 shares — an estimated $174K sold.

Cornerstone Investment Partners first reported a position in ORGO in Q1 2021 and held it in 10 quarters. The position peaked at $293K in Q1 2021. 121 funds tracked by Wall St. Rank hold ORGO as of Q1 2026.

Cornerstone Investment Partners reported no remaining Organogenesis Holdings position as of Q1 2026 after selling out during the quarter.
Cornerstone Investment Partners sold 33,627 Organogenesis Holdings shares in Q1 2026, an estimated $174K.
Cornerstone Investment Partners first reported a position in Organogenesis Holdings in Q1 2021 and held it in 10 quarters.
Cornerstone Investment Partners's Organogenesis Holdings position peaked at $293K in Q1 2021.
121 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q1 2026.

Based on Cornerstone Investment Partners's 13F filing for Q1 2026, filed 8 May 2026.